Glycemic Control and Bone Turnover in Older Mexican Americans with Type 2 Diabetes

Table 3

Multivariable association between sclerostin and HbA1c for Mexican American men and women diagnosed with T2D.

Variables	Men		Women
	Adjusted mean difference (95% CI)	value	Adjusted mean difference (95% CI)	value
HbA1c
Age ≥ 65 group	0.37 (−15.77, 16.50)	0.96	2.52 (−0.24, 5.28)	0.07
Age < 65 group	−1.80 (−14.20, 10.60)	0.72	2.45 (−0.19, 5.09)	0.07
BMI	−3.26 (−10.49, 3.96)	0.30	−0.93 (−1.73, −0.13)	0.02
Serum creatinine	−73.71 (−266.19, 118.77)	0.37	29.05 (10.82, 47.29)	0.003
Serum calcium	−33.54 (−528.40, 461.31)	0.87	0.15 (−48.80, 49.09)	0.99
Serum vitamin D	−0.96 (−2.56, 0.63)	0.18	0.03 (−0.21, 0.27)	0.82
Femur neck BMD	40.48 (−142.27, 223.22)	0.59	94.31 (47.77, 140.87)	0.0003
≥10 years since T2D diagnosis	11.93 (−35.99, 59.84)	0.55	4.43 (−4.49, 13.35)	0.32

Note. CI: confidence interval; interaction effect between HbA1c and age for men , for women .